| Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YLR250W | SSP120 | SGDID:S000004240 | CBL2 SCABP1 At5g55990 MDA7.3 |
Calcineurin B-like protein 2 (SOS3-like calcium-binding protein 1) |
Arabidopsis thaliana | 1uhn_a | Q8LAS7 | 97.30 | 1.20E-07 | 1.70E-11 | 65.90 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | NCS1 FLUP FREQ |
Neuronal calcium sensor 1 (NCS-1) (Frequenin homolog) (Frequenin-like protein) (Frequenin-like ubiquitous protein) |
Homo sapiens | Migraine With Or Without Aura 1,Dental Anomalies And Short Stature,Nystagmus 2, Congenital, Autosomal Dominant,Migraine With Aura,Acute Interstitial Pneumonia,Wolfram Syndrome,Bipolar Disorder,Disease Of Mental Health,Schizophrenia,Migraine, Familial Hemiplegic, 1,Familial Hemiplegic Migraine,Acrofacial Dysostosis,Acrofacial Dysostosis 1, Nager Type |
2lcp_a | P62166 | ENSG00000107130 | NCS1 | 97.30 | 1.20E-07 | 1.70E-11 | 65.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YLR250W | SSP120 | SGDID:S000004240 | PPP3R1 CNA2 CNB |
Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1) |
Homo sapiens | Alzheimer Disease,Amyotrophic Lateral Sclerosis 1,X-Linked Cerebellar Ataxia,Deafness, Autosomal Dominant 58,Crouzon Syndrome With Acanthosis Nigricans,Spinocerebellar Ataxia, X-Linked 3,Spinocerebellar Ataxia, X-Linked 4,Spinocerebellar Ataxia, X-Linked 1 |
3ll8_d | P63098 | ENSG00000221823 | PPP3R1 | 97.30 | 1.40E-07 | 2.00E-11 | 62.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YLR250W | SSP120 | SGDID:S000004240 | GUCA1A GCAP1 |
Guanylyl cyclase-activating protein 1 (GCAP 1) (Guanylate cyclase activator 1A) |
Gallus gallus | 2r2i_a | P79880 | 97.20 | 2.00E-07 | 2.90E-11 | 63.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | NUCB1 NUC |
Nucleobindin-1 (CALNUC) |
Homo sapiens | Ataxia, Sensory, 1, Autosomal Dominant,Cone-Rod Dystrophy 10 |
1snl_a | Q02818 | ENSG00000104805 | NUCB1 | 97.90 | 3.50E-09 | 4.60E-13 | 68.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YLR250W | SSP120 | SGDID:S000004240 | PPP2R3A PPP2R3 |
Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha (PP2A subunit B isoform PR72/PR130) (PP2A subunit B isoform R3 isoform) (PP2A subunit B isoforms B''-PR72/PR130) (PP2A subunit B isoforms B72/B130) (Serine/threonine-protein phosphatase 2A 72/130 kDa regulatory subunit B) |
Homo sapiens | Alzheimer Disease 15,Ventricular Tachycardia, Catecholaminergic Polymorphic, 1, With Or Without Atrial Dysfunction And/Or Dilated Cardiomyopathy,Ventricular Tachycardia, Catecholaminergic Polymorphic, 2,Syndromic Intellectual Disability |
4i5j_a | Q06190 | ENSG00000073711 | PPP2R3A | 97.40 | 1.10E-07 | 1.50E-11 | 71.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YLR250W | SSP120 | SGDID:S000004240 | CLSS |
Calsensin (LAN3-6 antigen) |
Haemopis marmorata | 1yx8_a | Q25088 | 97.20 | 2.80E-07 | 4.10E-11 | 53.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | FCA2 |
Flagellar calcium-binding protein TB-24 (24 kDa calcimedin) (24 kDa calflagin) |
Trypanosoma brucei | 2lvv_a | Q26680 | 97.00 | 6.50E-07 | 8.20E-11 | 66.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | OBL |
Obelin (OBL) |
Obelia longissima | 1qv1_a | Q27709 | 97.10 | 4.70E-07 | 6.40E-11 | 63.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | Tb927.7.3410 |
Tb927.7.3410 |
Trypanosoma brucei | 5zor_a | Q57WF6 | 97.00 | 6.30E-07 | 8.90E-11 | 58.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | scgn zgc:100843 |
Secretagogin |
Danio rerio | 2be4_a | Q5XJX1 | 97.70 | 1.20E-08 | 1.70E-12 | 73.60 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | RBOHB Os01g0360200 LOC_Os01g25820 B1164G11.26 OsJ_01746 |
Respiratory burst oxidase homolog protein B (EC 1.11.1.-) (EC 1.6.3.-) (NADPH oxidase RBOHB) (OsrbohB) |
1.11.1.-,1.6.3.-, | Oryza sativa | 3a8r_b | Q5ZAJ0 | 97.20 | 3.10E-07 | 4.10E-11 | 64.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| YLR250W | SSP120 | SGDID:S000004240 | Kcnip4 Calp Kchip4 |
Kv channel-interacting protein 4 (KChIP4) (A-type potassium channel modulatory protein 4) (Calsenilin-like protein) (Potassium channel-interacting protein 4) |
Mus musculus | 3dd4_a | Q6PHZ8 | 97.20 | 2.90E-07 | 3.70E-11 | 68.00 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | Chp1 Chp |
Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22) |
Rattus norvegicus | 2ct9_b | P61023 | 97.50 | 4.50E-08 | 5.90E-12 | 71.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | MCFD2 SDNSF |
Multiple coagulation factor deficiency protein 2 (Neural stem cell-derived neuronal survival protein) |
Homo sapiens | Factor Xiii Deficiency,Hemorrhagic Disease,Prothrombin Deficiency,Hemarthrosis,Brachydactyly, Type D,Factor V And Factor Viii, Combined Deficiency Of, 1,Factor V Deficiency,Factor V And Factor Viii, Combined Deficiency Of, 2,Thrombocytopenia,Venezuelan Hemorrhagic Fever,Factor Viii Deficiency,Good Syndrome |
3lcp_d | Q8NI22 | ENSG00000180398 | MCFD2 | 97.10 | 4.00E-07 | 5.50E-11 | 56.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YLR250W | SSP120 | SGDID:S000004240 | CALX calx |
CALX calx |
Ciona intestinalis | 5x9a_a | Q8T893 | 97.00 | 6.70E-07 | 8.60E-11 | 65.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | Cabp4 |
Calcium-binding protein 4 (CaBP4) |
Mus musculus | 2m29_a | Q8VHC5 | 97.00 | 7.30E-07 | 1.00E-10 | 59.80 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | CIB1 CIB KIP PRKDCIP |
Calcium and integrin-binding protein 1 (CIB) (Calcium- and integrin-binding protein) (CIBP) (Calmyrin) (DNA-PKcs-interacting protein) (Kinase-interacting protein) (KIP) (SNK-interacting protein 2-28) (SIP2-28) |
Homo sapiens | Pityriasis Versicolor,Alzheimer Disease,Breast Cancer,Epidermodysplasia Verruciformis 1,Skin Carcinoma,Schneiderian Carcinoma,Epidermodysplasia Verruciformis 3 |
1dgv_a | Q99828 | ENSG00000185043 | CIB1 | 97.20 | 3.20E-07 | 4.40E-11 | 63.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YLR250W | SSP120 | SGDID:S000004240 | SCO4411 |
SCO4411 |
Streptomyces coelicolor | 3akb_a | Q9F377 | 97.30 | 1.50E-07 | 2.10E-11 | 63.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | KCNIP1 KCHIP1 VABP |
Kv channel-interacting protein 1 (KChIP1) (A-type potassium channel modulatory protein 1) (Potassium channel-interacting protein 1) (Vesicle APC-binding protein) |
Homo sapiens | Hypertension, Diastolic,Bacterial Pneumonia,Episodic Ataxia, Type 4,Attention Deficit-Hyperactivity Disorder |
2i2r_f | Q9NZI2 | ENSG00000182132 | KCNIP1 | 97.40 | 6.50E-08 | 9.00E-12 | 66.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YLR250W | SSP120 | SGDID:S000004240 | CABP1 |
Calcium-binding protein 1 (CaBP1) (Calbrain) (Caldendrin) |
Homo sapiens | Tinea Nigra,Drug Psychosis,Drug-Induced Mental Disorder,Blastomycosis,Substance-Induced Psychosis,Spinal Cord Lymphoma,Mucolipidosis Iii Gamma |
3ox5_c | Q9NZU7 | ENSG00000157782 | CABP1 | 97.10 | 5.10E-07 | 7.20E-11 | 59.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YLR250W | SSP120 | SGDID:S000004240 | SLC25A13 ARALAR2 |
Calcium-binding mitochondrial carrier protein Aralar2 (Citrin) (Mitochondrial aspartate glutamate carrier 2) (Solute carrier family 25 member 13) |
Homo sapiens | Liver Disease,Bile Duct Disease,Citrullinemia, Classic,Amino Acid Metabolic Disorder,Urea Cycle Disorder,Fatty Liver Disease,Biliary Tract Disease,Brain Edema,Developmental And Epileptic Encephalopathy 39,Split-Hand/Foot Malformation 1 With Sensorineural Hearing Loss, Autosomal Recessive,Bilirubin Metabolic Disorder,Hepatic Encephalopathy,Cholestasis,Obstructive Jaundice,Citrullinemia, Type Ii, Adult-Onset,Galactosemia I,Asperger Syndrome,Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome,Hypermethioninemia,Citrullinemia, Type Ii, Neonatal-Onset,3-Methylcrotonyl-Coa Carboxylase Deficiency,Autosomal Recessive Disease,Mitochondrial Dna Depletion Syndrome 3,Bile Acid Synthesis Defect, Congenital, 1,Ornithine Transcarbamylase Deficiency, Hyperammonemia Due To,Argininemia,Argininosuccinic Aciduria,Carnitine Deficiency, Systemic Primary |
4p5w_a | Q9UJS0 | ENSG00000004864 | SLC25A13 | 97.10 | 4.50E-07 | 5.90E-11 | 72.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YLR250W | SSP120 | SGDID:S000004240 | Frq2 Dmel\CG5907 dNCS-1 Frq frq frq2 Frq2-RA CG5907 Dmel_CG5907 |
Frq2 Dmel\CG5907 dNCS-1 Frq frq frq2 Frq2-RA CG5907 Dmel_CG5907 |
Drosophila melanogaster | 5aan_a | Q9VWX8 | 97.40 | 1.00E-07 | 1.40E-11 | 64.90 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | KCNIP3 CSEN DREAM KCHIP3 |
Calsenilin (A-type potassium channel modulatory protein 3) (DRE-antagonist modulator) (DREAM) (Kv channel-interacting protein 3) (KChIP3) |
Homo sapiens | Alzheimer Disease,Familial Adult Myoclonic Epilepsy,Diamond-Blackfan Anemia 10,Diamond-Blackfan Anemia 20,Niemann-Pick Disease, Type C2,Ceroid Lipofuscinosis, Neuronal, 3 |
2e6w_a | Q9Y2W7 | ENSG00000115041 | KCNIP3 | 97.20 | 2.00E-07 | 2.80E-11 | 58.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YLR250W | SSP120 | SGDID:S000004240 | PPP2R3B PPP2R3L |
Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta (PP2A subunit B isoform PR48) (Protein phosphatase 2A 48 kDa regulatory subunit) |
Homo sapiens | Chronic Tic Disorder,Alzheimer Disease 15 |
4mew_a | Q9Y5P8 | ENSG00000167393 | PPP2R3B | 97.20 | 2.50E-07 | 3.30E-11 | 72.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YLR250W | SSP120 | SGDID:S000004240 | Mlc1 MLC-ALK CG5596 |
Myosin light chain alkali |
Drosophila melanogaster | 5w1a_b | P06742 | 97.00 | 7.70E-07 | 1.10E-10 | 59.00 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | CIMG_02704 |
CIMG_02704 |
Coccidioides immitis | 5b8i_b | A0A0D8JSK0 | 97.30 | 1.80E-07 | 2.50E-11 | 63.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | CTHT_0043240 |
CTHT_0043240 |
Chaetomium thermophilum | 4wpx_a | G0SAR7 | 97.30 | 1.60E-07 | 2.30E-11 | 63.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | BA2 BA1 BA3 BA4 |
BA2 BA1 BA3 BA4 |
Beroe abyssicola | 5bpj_a | H8ZZK1 | 97.10 | 4.30E-07 | 5.70E-11 | 65.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | EHI7A_088180 |
EHI7A_088180 |
Entamoeba histolytica | 4oci_a | N9UIU7 | 97.20 | 2.20E-07 | 3.10E-11 | 60.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | CHP2 HCA520 |
Calcineurin B homologous protein 2 (Hepatocellular carcinoma-associated antigen 520) |
Homo sapiens | Macs Syndrome,Hepatocellular Carcinoma |
2bec_a | O43745 | ENSG00000166869 | CHP2 | 97.40 | 1.00E-07 | 1.30E-11 | 68.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YLR250W | SSP120 | SGDID:S000004240 | cex |
cex |
Doryteuthis pealeii | 2ccm_a | O76764 | 97.10 | 5.50E-07 | 7.60E-11 | 62.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | CBL4 SOS3 At5g24270 MOP9.8 |
Calcineurin B-like protein 4 (Protein SALT OVERLY SENSITIVE 3) |
Arabidopsis thaliana | 2ehb_a | O81223 | 97.10 | 3.60E-07 | 4.80E-11 | 65.10 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | AEQ2 |
Aequorin-2 |
Aequorea victoria | 1uhh_a | P02592 | 97.20 | 2.70E-07 | 3.70E-11 | 64.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | MYLPF |
Myosin regulatory light chain 2, skeletal muscle isoform (DTNB) (Fast skeletal myosin light chain 2) (MLC-2) (G2) (LC2f) |
Gallus gallus | 1o1g_e | P02609 | 97.10 | 3.30E-07 | 4.80E-11 | 59.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | MLRM |
Myosin regulatory light chain 2, smooth muscle major isoform (MLC-2) (DTNB) (G1) (Isoform L20-A) |
Gallus gallus | 3j04_b | P02612 | 97.30 | 1.70E-07 | 2.40E-11 | 60.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | SCP |
Sarcoplasmic calcium-binding protein (SCP) |
Hediste diversicolor | 1q80_a | P04571 | 97.00 | 6.40E-07 | 8.70E-11 | 61.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | CDC31 DSK1 YOR257W |
Cell division control protein 31 (Nuclear pore protein CDC31) (Nucleoporin CDC31) |
Saccharomyces cerevisiae | 3fwb_a | P06704 | 97.00 | 6.80E-07 | 9.60E-11 | 59.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | S100A10 ANX2LG CAL1L CLP11 |
Protein S100-A10 (Calpactin I light chain) (Calpactin-1 light chain) (Cellular ligand of annexin II) (S100 calcium-binding protein A10) (p10 protein) (p11) |
Homo sapiens | Cannabis Dependence,Cholestasis, Intrahepatic, Of Pregnancy 3,Barrett'S Adenocarcinoma,Trachea Leiomyoma,Conjunctival Intraepithelial Neoplasm,Hyperoxaluria, Primary, Type Iii,Acute Promyelocytic Leukemia,Rectum Adenoma,Form Agnosia |
1a4p_a | P60903 | 98.50 | 1.70E-11 | 1.60E-15 | 90.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| YLR250W | SSP120 | SGDID:S000004240 | Calb1 |
Calbindin (Calbindin D28) (D-28K) (Spot 35 protein) (Vitamin D-dependent calcium-binding protein, avian-type) |
Rattus norvegicus | 2g9b_a | P07171 | 97.20 | 3.20E-07 | 4.60E-11 | 65.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | MLR |
Myosin regulatory light chain (Calcium-binding light chain) |
Physarum polycephalum | 2bl0_b | P08053 | 97.10 | 3.80E-07 | 5.40E-11 | 59.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | SPARC ON |
SPARC (Basement-membrane protein 40) (BM-40) (Osteonectin) (ON) (Secreted protein acidic and rich in cysteine) |
Homo sapiens | Bone Disease,Fibrous Dysplasia,Dentinogenesis Imperfecta,Aortic Valve Disease 2,Calcinosis,Melorheostosis,Chondrosarcoma,Myositis Ossificans,Tongue Carcinoma,Fibrosarcomatous Osteosarcoma,Extraosseous Ewings Sarcoma-Primitive Neuroepithelial Tumor,Quebec Platelet Disorder,Paget'S Disease Of Bone,Osteogenesis Imperfecta, Type Iv,Osseous Heteroplasia, Progressive,Osteoporosis,Aplastic Anemia,Ovarian Cancer,Breast Cancer,Open-Angle Glaucoma,Papillary Cystadenocarcinoma,Cystadenocarcinoma,Hepatocellular Carcinoma,Clear Cell Chondrosarcoma,Lateral Cystocele,Mccune-Albright Syndrome,Extraosseous Osteosarcoma,Bone Osteosarcoma,Conventional Central Osteosarcoma,Root Resorption,Cone-Rod Dystrophy 2,Prostate Cancer,Brittle Bone Disorder,Pulmonary Fibrosis, Idiopathic,Thrombocytopenia,Pericoronitis,Odontochondrodysplasia,Gray Platelet Syndrome,Vitreoretinopathy, Neovascular Inflammatory,Osteogenesis Imperfecta, Type Xvii,Meningioma, Familial,Osteofibrous Dysplasia,Osteoblastoma,Lung Cancer,Osteogenic Sarcoma,Osteoporosis, Juvenile,Pancreatic Cancer,Pseudoxanthoma Elasticum,Pycnodysostosis |
1bmo_b | P09486 | ENSG00000113140 | SPARC | 97.10 | 4.90E-07 | 5.30E-11 | 72.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YLR250W | SSP120 | SGDID:S000004240 | DMD |
Dystrophin |
Homo sapiens | Muscular Disease,Brody Myopathy,Bone Structure Disease,Heart Disease,X-Linked Recessive Disease,Hemophagocytic Lymphohistiocytosis, Familial, 1,Congenital Fiber-Type Disproportion,Myoglobinuria,Retinitis Pigmentosa,Myopathy,Gas Gangrene,Myofibrillar Myopathy,Atrial Heart Septal Defect,Emery-Dreifuss Muscular Dystrophy,Muscle Tissue Disease,Exophthalmos,Neuromuscular Disease,Bethlem Myopathy 1,Hypertrophic Cardiomyopathy,Facioscapulohumeral Muscular Dystrophy 1,Symptomatic Form Of Muscular Dystrophy Of Duchenne And Becker In Female Carriers,Familial Isolated Dilated Cardiomyopathy,Progressive Muscular Dystrophy,Autosomal Dominant Distal Myopathy,Cytoplasmic Body Myopathy,Myositis,Interatrial Communication,Myotonic Dystrophy 1,Myopathy, Myofibrillar, 1,Extracardiac Rhabdomyoma,Spinal Muscular Atrophy,Autosomal Recessive Limb-Girdle Muscular Dystrophy,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2a,Muscular Dystrophy,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2b,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2c,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2d,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2f,Retinal Ischemia,Tibial Muscular Dystrophy,Hypertrophic Pyloric Stenosis,Congenital Muscular Dystrophy-Dystroglycanopathy Type A,Isolated Elevated Serum Creatine Phosphokinase Levels,Reducing Body Myopathy,Interstitial Myocarditis,Myocarditis,Atrial Standstill 1,Cataract,Immunodeficiency 26,Dilated Cardiomyopathy,Dystrophinopathies,Glycogen Storage Disease,Fundus Dystrophy,Nr0b1-Related Adrenal Hypoplasia Congenita,Long Qt Syndrome,Malignant Hyperthermia,Muscular Dystrophy, Congenital, Lmna-Related,Cobblestone Lissencephaly,Localized Lipodystrophy,Waardenburg Syndrome, Type 4b,Eye Disease,Myopathy, Myofibrillar, 3,Colorectal Cancer,Peripheral Nervous System Disease,Pectus Excavatum,Cardiomyopathy, Familial Hypertrophic, 4,Endocardial Fibroelastosis,Myopathy, Myofibrillar, 5,Rhabdomyosarcoma,Rigid Spine Muscular Dystrophy 1,Respiratory Failure,Centronuclear Myopathy,Disease Of Mental Health,Adrenal Hypoplasia, Congenital,Creatine Phosphokinase, Elevated Serum,Glycogen Storage Disease Ii,Muscular Dystrophy, Becker Type,Oculomedin,Aland Island Eye Disease,Emery-Dreifuss Muscular Dystrophy 2, Autosomal Dominant,Polyglucosan Body Myopathy 1 With Or Without Immunodeficiency,Schizophrenia,Restrictive Cardiomyopathy,Chromosome Xp21 Deletion Syndrome,Beckwith-Wiedemann Syndrome,Arrhythmogenic Right Ventricular Cardiomyopathy,Brugada Syndrome,Mcleod Syndrome,Lissencephaly,Walker-Warburg Syndrome,Muscle Hypertrophy,Nonaka Myopathy,Muscular Dystrophy-Dystroglycanopathy,X-Linked Monogenic Disease,Non-Syndromic X-Linked Intellectual Disability,Cardiomyopathy, Dilated, 3b,Cardioneuromyopathy With Hyaline Masses And Nemaline Rods,Cardiomyopathy, Familial Hypertrophic, 1,Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome,Intrinsic Cardiomyopathy,Autism Spectrum Disorder,Glycerol Kinase Deficiency,Keratosis Follicularis Spinulosa Decalvans, X-Linked,Microcolon,Scoliosis,Ptosis,Muscular Dystrophy, Duchenne Type,Muscular Dystrophy, Congenital Merosin-Deficient, 1a,Muscular Dystrophy, Limb-Girdle, Autosomal Recessive 2,Muscular Dystrophy-Dystroglycanopathy , Type A, 4,Ullrich Congenital Muscular Dystrophy 1,Retinoschisis 1, X-Linked, Juvenile,Left Ventricular Noncompaction,Autism,Batten-Turner Congenital Myopathy,Miyoshi Muscular Dystrophy,Multiple Pterygium Syndrome, Escobar Variant |
1eg3_a | P11532 | ENSG00000198947 | DMD | 97.30 | 1.60E-07 | 2.00E-11 | 72.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YLR250W | SSP120 | SGDID:S000004240 | RCVRN RCV1 |
Recoverin (p26) |
Bos taurus | 4yi8_a | P21457 | 97.50 | 4.90E-08 | 6.60E-12 | 69.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | DGKA DAGK DAGK1 |
Diacylglycerol kinase alpha (DAG kinase alpha) (EC 2.7.1.107) (80 kDa diacylglycerol kinase) (Diglyceride kinase alpha) (DGK-alpha) |
2.7.1.107 | Homo sapiens | Fibrosclerosis Of Breast,Lymphoproliferative Syndrome, X-Linked, 1 |
6iie_a | P23743 | ENSG00000065357 | DGKA | 97.40 | 1.00E-07 | 1.50E-11 | 57.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| YLR250W | SSP120 | SGDID:S000004240 | MLRT |
Myosin regulatory light chain 2, skeletal muscle isoform type 1 (DTNB) (Fast skeletal myosin light chain 2) (G2) (MLC-2) |
Oryctolagus cuniculus | 5h53_b | P24732 | 97.20 | 2.10E-07 | 2.90E-11 | 61.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | HPCAL1 BDR1 |
Hippocalcin-like protein 1 (Calcium-binding protein BDR-1) (HLP2) (Visinin-like protein 3) (VILIP-3) |
Homo sapiens | Alzheimer Disease,Branchiootorenal Syndrome 2 |
5t7c_a | P37235 | ENSG00000115756 | HPCAL1 | 97.50 | 5.70E-08 | 8.00E-12 | 67.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YLR250W | SSP120 | SGDID:S000004240 | MI17 |
Mitrocomin |
Mitrocoma cellularia | 4nqg_a | P39047 | 97.00 | 7.80E-07 | 1.10E-10 | 62.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YLR250W | SSP120 | SGDID:S000004240 | CETN2 CALT CEN2 |
Centrin-2 (Caltractin isoform 1) |
Homo sapiens | Retinitis Pigmentosa,Polyposis Syndrome, Hereditary Mixed, 1,Xeroderma Pigmentosum Group E,Hereditary Mixed Polyposis Syndrome,Xeroderma Pigmentosum, Complementation Group C,Xeroderma Pigmentosum, Complementation Group D,Xeroderma Pigmentosum, Variant Type,Xeroderma Pigmentosum, Complementation Group G,Xeroderma Pigmentosum, Complementation Group B,Ck Syndrome,Trichothiodystrophy 3, Photosensitive,Uv-Sensitive Syndrome,Bardet-Biedl Syndrome 1,Joubert Syndrome 1,Isolated Growth Hormone Deficiency, Type Ia |
2obh_b | P41208 | ENSG00000147400 | CETN2 | 97.10 | 4.20E-07 | 6.10E-11 | 58.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| YLR250W | SSP120 | SGDID:S000004240 | Acam And Camr97A CG17769 |
Calmodulin-related protein 97A (Protein androcam) |
Drosophila melanogaster | 2lmt_a | P49258 | 97.20 | 3.00E-07 | 4.20E-11 | 60.40 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |